Glial reactions in Parkinson's disease

McGeer, Patrick L., McGeer, Edith G.·2008·Movement Disorders

DOI 10.1002/mds.21751

Cited by (700)

Items 101–200 of 700

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies
Karen Rees, Rebecca L. Stowe, Smitaa Patel, Natalie J. Ives, Kieran C. Breen, Carl E Clarke, Yoav Ben‐Shlomo · 2011 · Cochrane Database of Systematic Reviews
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Juan Manuel Zolezzi, Manuel J. Santos, Sussy Bastias Candia, Claudio Pinto, Juan Alejandro Godoy, Nibaldo C. Inestrosa · 2017 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson’s disease
Young Cheul Chung, Jeong Yeob Baek, Sang Ryong Kim, Hyuk Wan Ko, Eugene Bok, Won-Ho Shin, So-Yoon Won, Byung Kwan Jin · 2017 · Experimental & Molecular Medicine
Effects of Hydrogen Sulfide-releasing l-DOPA Derivatives on Glial Activation
Moon‐Hee Lee, Valerio Tazzari, Daniela Giustarini, Ranieri Rossi, Anna Sparatore, Piero Del Soldato, Edith G. McGeer, Patrick L. McGeer · 2010 · Journal of Biological Chemistry
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease
Mariza Bortolanza, Roberta Cavalcanti-Kwiatkoski, Fernando E. Padovan‐Neto, Célia Aparecida da-Silva, Mišo Mitkovski, Rita Raisman‐Vozari, Elaine Aparecida Del Bel · 2014 · Neurobiology of Disease
Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System
Byung-Wook Kim, Kyoung Hoon Jeong, Jae‐Hong Kim, Myungwon Jin, Jong‐Heon Kim, Maan‐Gee Lee, Dong‐Kug Choi, So-Yoon Won, Catriona McLean, Min‐Tae Jeon et al. · 2016 · Journal of Neuroscience
Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades
Mei-Jen Wang, Hsin‐Yi Huang, Wu-Fu Chen, Hui‐Fen Chang, Jon‐Son Kuo · 2010 · Journal of Neuroinflammation
Phagocytic Clearance in Neurodegeneration
Jennifer D. Sokolowski, James William Mandell · 2011 · American Journal Of Pathology
Delayed Dominant-Negative TNF Gene Therapy Halts Progressive Loss of Nigral Dopaminergic Neurons in a Rat Model of Parkinson's Disease
Ashley S. Harms, Christopher J. Barnum, Kelly A. Ruhn, Steve Varghese, Isaac Treviño, Armin Blesch, Malú G. Tansey · 2010 · Molecular Therapy
Regulator of G-Protein Signaling 10 Promotes Dopaminergic Neuron Survival via Regulation of the Microglial Inflammatory Response
Jae‐Kyung Lee, Melissa K. McCoy, Ashley S. Harms, Kelly A. Ruhn, Stephen J. Gold, Malú G. Tansey · 2008 · Journal of Neuroscience
Exercise protects against MPTP-induced neurotoxicity in mice
Kimberly M. Gerecke, Yun Jiao, Amar K. Pani, Vishwajeeth Pagala, Richard Jay Smeyne · 2010 · Brain Research
Iron uptake in quiescent and inflammation-activated astrocytes: A potentially neuroprotective control of iron burden
Ilaria Pelizzoni, Daniele Zacchetti, Alessandro Campanella, Fabio Grohovaz, Franca Codazzi · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications
Juan Pedro Bolaños · 2010 · Frontiers in Neuroenergetics
Brain region-specific gene expression profiles in freshly isolated rat microglia
Karlijn J. Doorn, John J. P. Brevé, Benjamin Drukarch, H. W. G. M. Boddeke, Inge Huitinga, Paul John Lucassen, Anne‐Marie van Dam · 2015 · Frontiers in Cellular Neuroscience
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Eveljn Scarian, Camilla Viola, Francesca Dragoni, Rosalinda Di Gerlando, Bartolo Rizzo, Luca Diamanti, Stella Gagliardi, Matteo Bordoni, Orietta Pansarasa · 2024 · International Journal of Molecular Sciences
Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression
Грудень Марина Алексеевна, Robert D. E. Sewell, Kiran Yanamandra, T.V. Davidova, V. G. Kucheryanu, Evgeny V. Bocharov, Olga A. Bocharova, Vsevolod V. Polyschuk, Vladimir V. Sherstnev, Ludmilla A. Morozova‐Roche · 2011 · Journal of Neuroimmunology
Translational potential of astrocytes in brain disorders
Alexei Verkhratsky, Luca Steardo, Vladimir Parpura, Vedrana Montana · 2015 · Progress in Neurobiology
Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation
Junchao Tong, Lee-Cyn Ang, Belinda Williams, Yoshiaki Furukawa, Paul S. Fitzmaurice, Mark Guttman, Isabelle Boileau, Oleh Hornykiewicz, Stephen J. Kish · 2015 · Neurobiology of Disease
MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain
Dario Domenico Lofrumento, Concetta Saponaro, Antonia Cianciulli, Francesco De Nuccio, Vincenzo Mitolo, Giuseppe Nicolardi, Maria Antonietta Panaro · 2010 · NeuroImmunoModulation
DJ ‐1 deficiency triggers microglia sensitivity to dopamine toward a pro‐inflammatory phenotype that is attenuated by rasagiline
Dorit Trudler, Orly Weinreb, Silvia A. Mandel, Moussa B. H. Youdim, Dan Frenkel · 2013 · Journal of Neurochemistry
Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
Villar-Cheda, Begoña, Dominguez-Meijide, Antonio, Joglar, Belen, Rodriguez-Perez, Ana I., Guerra, Maria J., Labandeira-Garcia, Jose L. · 2012 · Neurobiology of Disease
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
Kemal Uğur Tüfekçi, Şermin Genç, Kürşad Genç · 2011 · Parkinson s Disease
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
Rojanathammanee, Lalida, Murphy, Eric J, Combs, Colin K · 2011 · Journal of Neuroinflammation
Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive Intermediate
Jinsmaa, Yunden, Florang, Virginia R., Rees, Jennifer N., Anderson, David G., Strack, Stefan, Doorn, Jonathan A. · 2009 · Chemical Research in Toxicology
BMAL1 regulation of microglia‐mediated neuroinflammation in MPTP‐induced Parkinson's disease mouse model
Wenwen Liu, Shizhuang Wei, Guodong Huang, Lu-Bing Liu, Chao Gu, Yun Shen, Xianhui Wang, Shu‐Ting Xia, Anmu Xie, Li‐Fang Hu et al. · 2020 · The FASEB Journal
Impact of Environmental Risk Factors on Mitochondrial Dysfunction, Neuroinflammation, Protein Misfolding, and Oxidative Stress in the Etiopathogenesis of Parkinson’s Disease
Minhong Huang, Alejandra Bargues-Carot, Zainab Riaz, Hannah Wickham, Gary D. Zenitsky, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2022 · International Journal of Molecular Sciences
Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
Mariza Bortolanza, Glauce Crivelaro Nascimento, Sergio B. Socías, Diego Ploper, Rosana Nieves Chehín, Rita Raisman‐Vozari, Elaine Aparecida Del Bel · 2018 · Journal of Neural Transmission
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Hyejin Jeon, Jong‐Heon Kim, Jae‐Hong Kim, Won‐Ha Lee, Myung‐Shik Lee, Kyoungho Suk · 2012 · Journal of Neuroinflammation
The impact of glial activation in the aging brain.
Aileen M. Lynch, Kevin J Murphy, Brian F. Deighan, Julie-Ann O’Reilly, Yurii K. Gun’ko, Thelma R. Cowley, Rodrigo E. González-Reyes, Marina A. Lynch · 2010 · Europe PMC (PubMed Central)
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease
Ruwani Wijeyekoon, Deborah Kronenberg‐Versteeg, Kirsten M. Scott, Shaista Hayat, Wei‐Li Kuan, Jonathan Evans, David P. Breen, Gemma A. Cummins, Joanne Jones, Menna Ruth Clatworthy et al. · 2020 · Brain Behavior and Immunity
Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
Alejandra Camacho‐Soto, Anat Gross, Susan Searles Nielsen, Neelendu Dey, Brad Alan Racette · 2018 · Parkinsonism & Related Disorders
Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
Takakuni Maki, Kazuhide Hayakawa, Loc−Duyen D. Pham, Changhong Xing, Eng H. Lo, Ken Arai · 2013 · CNS & Neurological Disorders - Drug Targets
A Cross-Study Transcriptional Analysis of Parkinson's Disease
Greg Trevor Sutherland, Nicholas Matigian, Alistair Morgan Chalk, Matthew J. Anderson, Peter A. Silburn, Alan Mackay‐Sim, Christine Anne Wells, George D. Mellick · 2009 · PLoS ONE
Parkinson's Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
Peter G. Jenner, Huw R. Morris, Trevor William Robbins, Michel Goedert, John Hardy, Yoav Ben‐Shlomo, J. Paul Bolam, David John Burn, John Vincent Hindle, David James Brooks et al. · 2013 · Journal of Parkinson s Disease
Role of microglial redox balance in modulation of neuroinflammation
Nadia Giselle Innamorato, Isabel Lastres‐Becker, Antonio Cuadrado · 2009 · Current Opinion in Neurology
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
Karlijn J. Doorn, Paul John Lucassen, H. W. G. M. Boddeke, Marloes Prins, Henk W. Berendse, Benjamin Drukarch, Anne‐Marie van Dam · 2012 · Progress in Neurobiology
The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
Anna Zinger, Carlos Barcia, María Trinidad Herrero, Gilles J. Guillemin · 2011 · Parkinson s Disease
Demethoxycurcumin, a natural derivative of curcumin attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-κB signaling pathways in N9 microglia induced by lipopolysaccharide
Lijia Zhang, Chunfu Wu, Siqi Zhao, Dan Yuan, Guoning Lian, Xiaoxiao Wang, Lihui Wang, Jingyu Yang · 2009 · International Immunopharmacology
Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for neuroprotection
Elżbieta Janda, Antonella Lascala, Cristina Carresi, Maddalena Parafati, Serafina Aprigliano, Vanessa Russo, Claudia Savoia, Elena Ziviani, Vincenzo Musolino, Federica Morani et al. · 2015 · Autophagy
Immunotherapy for Parkinson’s disease
Aaron D. Schwab, Mackenzie J. Thurston, Jatin Machhi, Katherine E. Olson, Krista L. Namminga, Howard Eliot Gendelman, Rodney Lee Mosley · 2020 · Neurobiology of Disease
Bee Venom Reduces Neuroinflammation in the MPTP-Induced Model of Parkinson's Disease
Jong‐In Kim, Eun Jin Yang, Myeong Soo Lee, Yong Suk Kim, Youngbuhm Huh, Ik‐Hyun Cho, Sung-Keel Kang, Hyung-Kyun Koh · 2011 · International Journal of Neuroscience
Inflammation in transgenic mouse models of neurodegenerative disorders
Schwab, Claudia, Klegeris, Andis, McGeer, Patrick. L. · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
Da‐Wei Li, Zhiqiang Liu, Wei‐Chen, MIN-YAO, Guang‐Ren Li · 2014 · Molecular Medicine Reports
Aging-InducedNrf2-AREPathway Disruption in the Subventricular Zone Drives Neurogenic Impairment in Parkinsonian Mice viaPI3K-Wnt/β-CateninDysregulation
Francesca L’Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C. Morale, Francesco Impagnatiello, Stefano Pluchino, Bianca Marchetti · 2013 · Journal of Neuroscience
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection
Thi Anh Thu Tran, Melissa K. McCoy, Michael B. Sporn, Malú G. Tansey · 2008 · Journal of Neuroinflammation
Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson’s Disease
Palasz, Ewelina, Niewiadomski, Wiktor, Gasiorowska, Anna, Wysocka, Adrianna, Stepniewska, Anna, Niewiadomska, Grazyna · 2019 · Frontiers in Neurology
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
Gesine Paul, Osama F. Elabi · 2022 · Frontiers in Aging Neuroscience
Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation
Linda B Moran, Manuel B. Graeber · 2008 · Neurogenetics
Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
Emma Thornton, Robert Vink · 2012 · PLoS ONE
Immunological features of α‐synuclein in Parkinson's disease
Cintia Roodveldt, John C. Christodoulou, Christopher Martin Dobson · 2008 · Journal of Cellular and Molecular Medicine
Comorbidities in Neurology: Is adenosine the common link?
Detlev Boison, Eleonora Aronica · 2015 · Neuropharmacology
Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases
Jéssica M. de Souza, Bruno Daniel Correia Gonçalves, Marcus V. Gomez, Luciene Bruno Vieira, Fabiola Mara Ribeiro · 2018 · Frontiers in Pharmacology
Pathophysiological roles for purines
Micaela Morelli, Anna Rosa Carta, Anil Kachroo, Michael A. Schwarzschild · 2010 · Progress in brain research
Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
Paula A. Videira, Margarida Castro‐Caldas · 2018 · Frontiers in Neuroscience
Caspase-8 in inflammatory diseases: a potential therapeutic target
Wangzheqi Zhang, Chenglong Zhu, Yan Liao, Miao Zhou, Wenyun Xu, Zui Zou · 2024 · Cellular & Molecular Biology Letters
Chronic exercise ameliorates the neuroinflammation in mice carrying NSE/htau23
Yea‐Hyun Leem, Young-Ik Lee, Hee-Jeong Son, Sangho Lee · 2011 · Biochemical and Biophysical Research Communications
Chronic and progressive Parkinson's disease MPTP model in adult and aged mice
Ana B. Muñoz‐Manchado, Javier Villadiego, Sonia Romo‐Madero, Nela Suárez‐Luna, Alfonso Bermejo‐Navas, José A. Rodríguez‐Gómez, Pablo Garrido‐Gil, José Luis Labandeira-García, Miriam Echevarrı́a, José López‐Barneo et al. · 2015 · Journal of Neurochemistry
Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra
Yang Heng, Qiu-Shuang Zhang, Zheng Mu, Jin‐Feng Hu, Yu‐He Yuan, Nai‐Hong Chen · 2015 · Toxicology Letters
Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration
Wei Zhang, Zhaofen Yan, Junhua Gao, Li Sun, Xiyan Huang, Zhuo Liu, Shuyang Yu, Chen-Jie Cao, Li-jun Zuo, Zejie Chen et al. · 2013 · Molecular Neurobiology
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients
Amandeep Mann, Sharon L. Miksys, Andrea Gaedigk, Stephen J. Kish, Deborah C. Mash, Rachel Fynvola Tyndale · 2011 · Neurobiology of Aging
Uncovering novel actors in astrocyte–neuron crosstalk in P arkinson's disease: the W nt/β‐catenin signaling cascade as the common final pathway for neuroprotection and self‐repair
Bianca Marchetti, Francesca L’Episcopo, Maria C. Morale, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Francesca Serapide, Stefano Pluchino · 2013 · European Journal of Neuroscience
Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes
Yang, Ruicheng, Yang, Bo, Liu, Wei, Tan, Chen, Chen, Huanchun, Wang, Xiangru · 2023 · Journal of Neuroinflammation
Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system
Hernández-Romero, Mª Carmen, Delgado-Cortés, Mª José, Sarmiento, Manuel, de Pablos, Rocío M., Espinosa-Oliva, Ana María, Argüelles, Sandro, Bández, Manuel J., Villarán, Ruth F., Mauriño, Raquel, Santiago, Marti et al. · 2012 · NeuroToxicology
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease
Nicoletta Schintu, Lucia Frau, Marcello Ibba, Arianna Garau, Ezio Carboni, Anna Rosa Carta · 2009 · Neurotoxicity Research
Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators
J. Saravanan, Praveen Thaggikuppe Krishnamurthy · 2021 · Neurochemistry International
Neuroprotective Effect of Curcuminoids Against Inflammation-Mediated Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease
Rudra Prakash Ojha, Manisha Rastogi, B. Parimala Devi, Aruna Agrawal, Govind Prasad Dubey · 2012 · Journal of Neuroimmune Pharmacology
Neurochemistry and the non-motor aspects of PD
Isidró Ferrer, Irene López‐González, Margarita Carmona, Esther Dalfó, Aurora Pujol, Ana Martı́nez · 2011 · Neurobiology of Disease
Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis
Wagdy K. B. Khalil, Naglaa Assaf, Shaimaa Ahmed ElShebiney, Neveen A. Salem · 2014 · Neurochemistry International
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
Diana Fernández‐Suárez, Marta Celorrio, José Ignacio Riezu‐Boj, Ana Ugarte, Rodrigo Pacheco, Hugo González, Julen Oyarzábal, Cecilia J. Hillard, Rafael Franco, María S. Aymerich · 2014 · Neurobiology of Aging
Brain-Region-Specific Astroglial Responses In Vitro After LPS Exposure
Markus Kipp, Akvilė Norkutė, Sonja Johann, Leila Lorenz, Alena Braun, Andrea Hieble, Stefan Gingele, Friederike Pott, Janek Richter, Cordian Beyer · 2008 · Journal of Molecular Neuroscience
Anti-melanin antibodies are increased in sera in Parkinson's disease
Kay L. Double, Dominic B. Rowe, Francine Carew‐Jones, M. Hayes, Daniel Kam Yin Chan, Jeffrey Blackie, Alastair J. Corbett, Ron Joffe, Victor S.C. Fung, John G. Morris et al. · 2009 · Experimental Neurology
Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain
Francesca L’Episcopo, Cataldo Tirolo, Maria Francesca Serapide, Salvatore Caniglia, Nunzio Testa, Loredana Leggio, Silvia Vivarelli, Nunzio Iraci, Stefano Pluchino, Bianca Marchetti · 2018 · Frontiers in Aging Neuroscience
Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions
James A. Varley, David James Brooks, Paul Edison · 2014 · Alzheimer s & Dementia
Microglia activation is related to substantia nigra echogenicity
Daniela Berg, Jana Godau, Peter Franz Riederer, M. Gerlach, Thomas Arzberger · 2010 · Journal of Neural Transmission
Molecular subtypes of ALS are associated with differences in patient prognosis
Jarrett Eshima, Samantha A. O’Connor, Ethan Marschall, Robert P. Bowser, Christopher L. Plaisier, Barbara S. Smith · 2023 · Nature Communications
Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study
Ling Shan, Koen Bossers, Sabina Luchetti, Rawien A. Balesar, Natasha L. Lethbridge, Paul Louis Chazot, Ai‐Min Bao, Dick Frans Swaab · 2011 · Neurobiology of Aging
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Beurel, Eléonore · 2011 · Frontiers in Molecular Neuroscience
Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity <i>via</i> AMPK/SOD2 Pathway
Xie, Zhenchao, Zhang, Mahui, Luo, Yuqi, Jin, Dana, Guo, Xingfang, Yang, Wanlin, Zheng, Jialing, Zhang, Hongfei, Zhang, Lu, Deng, Chao et al. · 2023 · Aging and disease
Apoptosis of peripheral blood lymphocytes in Parkinson patients
Matilde Calopa, Jordi Bas, Antonio Callén, Mariona Mestre · 2010 · Neurobiology of Disease
Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson’s Disease?
Christopher J. Barnum, Malú G. Tansey · 2012 · Current Neurology and Neuroscience Reports
In vitro and in vivo anti-inflammatory effect of Rhodomyrtus tomentosa methanol extract
Deok Jeong, Woo Seok Yang, Yanyan Yang, Gyeongsug Nam, Ji Hye Kim, Deok Hyo Yoon, Hyung Jun Noh, Sukchan Lee, Tae‐Woong Kim, Gi‐Ho Sung et al. · 2013 · Journal of Ethnopharmacology
Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system
Afrah Abdul Ismaiel, Ana M. Espinosa‐Oliva, Martiniano Santiago, Albert García-Quintanilla, Maria José Oliva-Martín, Antonio J. Herrera, Jose Luis Venero, Rocío M. de Pablos · 2016 · Toxicology and Applied Pharmacology
Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson’s disease: Role of regulatory T cells
Eun Sook Chung, Himchan Kim, Gihyun Lee, Soojin Park, Hyunseong Kim, Hyunsu Bae · 2012 · Brain Behavior and Immunity
Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease
Francesca L’Episcopo, Cataldo Tirolo, Salvatore Caniglia, Nunzio Testa, Maria C. Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti · 2014 · Journal of Molecular Cell Biology
S‐Glutathionylation of Keap1: a new role for glutathioneS‐transferase pi in neuronal protection
Andreia Neves Carvalho, Carla Marques, Rita Cardoso Guedes, Margarida Castro‐Caldas, Elsa Rodrigues, Jack van Horssen, Maria João Gama · 2016 · FEBS Letters
Manganese exposure facilitates microglial JAK2-STAT3 signaling and consequent secretion of TNF-a and IL-1β to promote neuronal death
Lifeng Yin, Qijun Dai, Peipei Jiang, Lin Dan Zhu, Haifeng Dai, Zhigang Yao, Hua Liu, Xiaoping Ma, Lianxia Qu, Junkang Jiang · 2017 · NeuroToxicology
Up-regulation of metallothionein gene expression in Parkinsonian astrocytes
Gregory J. Michael, Sharmin Esmailzadeh, Linda B Moran, LoBue Christian, R. K. B. Pearce, Manuel B. Graeber · 2011 · Neurogenetics
Ethyl Pyruvate Rescues Nigrostriatal Dopaminergic Neurons by Regulating Glial Activation in a Mouse Model of Parkinson’s Disease
Sue Hee Huh, Young Cheul Chung, Ying Piao, Min Y Jin, Hyo Jin Son, Nam Soo Yoon, Joo Y. Hong, Youngmi Kim Pak, Yoon S. Kim, Jong Ki Hong et al. · 2011 · The Journal of Immunology
Relationship Between Obesity, Alzheimer’s Disease, and Parkinson’s Disease: an Astrocentric View
Cynthia Martín-Jiménez, Diana Milena Gaitán-Vaca, Valentina Echeverrı́a, Janneth González, George Emilio Barreto · 2016 · Molecular Neurobiology
TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson’s Disease
Xiao Chen, Zhan Liu, Beibei Cao, Yihua Qiu, Yu-Ping Peng · 2017 · Journal of Neuroimmune Pharmacology
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
Antonella Cardinale, Valeria Calabrese, Antonio de Iure, Barbara Picconi · 2021 · International Journal of Molecular Sciences
Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges
Annalucia Serafino, Daniela Giovannini, Simona Rossi, Mauro Cozzolino · 2020 · Expert Opinion on Drug Discovery
Recent advances in Parkinson’s disease genetics
Steven J Lubbe, Huw R. Morris · 2013 · Journal of Neurology
Astrocytes and Microglia: Responses to Neuropathological Conditions
Sarika Singh, Supriya Swarnkar, Poonam Goswami, Chandishwar Nath · 2011 · International Journal of Neuroscience
Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease
Peng Tang, Chong Li, Xiaoqing Li, Yue Liu, Peng Liu, Chen Hou, Rui Li · 2014 · Oxidative Medicine and Cellular Longevity
Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases
Ana Raquel Santiago, Filipa I. Baptista, Paulo F. Santos, Gonçalo Cristóvão, António Francisco Ambrósio, Rodrigo Antunes Cunha, Catarina A. Gomes · 2014 · Mediators of Inflammation
Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice
Machado, Venissa, Zöller, Tanja, Attaai, Abdelraheim, Spittau, Björn · 2016 · International Journal of Molecular Sciences
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Simoneide Souza Titze-de-Almeida, Cristina Soto‐Sánchez, Eduardo Fernández, James B. Koprich, Jonathan M. Brotchie, Ricardo Titze‐de‐Almeida · 2020 · Cells
l ‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Anna Rosa Carta, Giovanna Mulas, Mariza Bortolanza, Terence Teixeira Duarte, Elisabetta Pillai, Gilberto Fisone, Rita Raisman‐Vozari, Elaine Aparecida Del Bel · 2016 · European Journal of Neuroscience
Time-course behavioral features are correlated with Parkinson's disease‑associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model
Rui‑Jun Su, Junli Zhen, Wei Wang, Jian‐Liang Zhang, Yan Zheng, Xiaomin Wang · 2017 · Molecular Medicine Reports